First Time Loading...

Vivos Therapeutics Inc
NASDAQ:VVOS

Watchlist Manager
Vivos Therapeutics Inc Logo
Vivos Therapeutics Inc
NASDAQ:VVOS
Watchlist
Price: 2.59 USD 5.28% Market Closed
Updated: Apr 29, 2024

Vivos Therapeutics Inc
Net Income (Common)

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Vivos Therapeutics Inc
Net Income (Common) Peer Comparison

Comparables:
DVA
DGX
CVS
CI
LH

Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors

Company Net Income (Common) CAGR 3Y CAGR 5Y CAGR 10Y
Vivos Therapeutics Inc
NASDAQ:VVOS
Net Income (Common)
-$13.6m
CAGR 3-Years
-4%
CAGR 5-Years
-10%
CAGR 10-Years
N/A
DaVita Inc
NYSE:DVA
Net Income (Common)
$691.5m
CAGR 3-Years
-4%
CAGR 5-Years
34%
CAGR 10-Years
1%
Quest Diagnostics Inc
NYSE:DGX
Net Income (Common)
$843m
CAGR 3-Years
-22%
CAGR 5-Years
3%
CAGR 10-Years
0%
CVS Health Corp
NYSE:CVS
Net Income (Common)
$8.3B
CAGR 3-Years
5%
CAGR 5-Years
N/A
CAGR 10-Years
6%
Cigna Corp
NYSE:CI
Net Income (Common)
$5.2B
CAGR 3-Years
-15%
CAGR 5-Years
14%
CAGR 10-Years
13%
Laboratory Corporation of America Holdings
NYSE:LH
Net Income (Common)
$433.1m
CAGR 3-Years
-45%
CAGR 5-Years
-14%
CAGR 10-Years
-2%

See Also

What is Vivos Therapeutics Inc's Net Income (Common)?
Net Income (Common)
-13.6m USD

Based on the financial report for Dec 31, 2023, Vivos Therapeutics Inc's Net Income (Common) amounts to -13.6m USD.

What is Vivos Therapeutics Inc's Net Income (Common) growth rate?
Net Income (Common) CAGR 5Y
-10%

Over the last year, the Net Income (Common) growth was 43%. The average annual Net Income (Common) growth rates for Vivos Therapeutics Inc have been -4% over the past three years , -10% over the past five years .